<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Txt>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE315nnn/GSE315100/suppl/GSE315100_raw_counts_all_samples_DLK1_Bang.txt.gz</Txt><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE315nnn/GSE315100/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315100</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Soluble DLK1 secreted by telomere-shortening-induced senescent microglia impairs oligodendrocyte functions and alters neuronal activity(ipsc_cell)</name><description>Aging is a predominant risk factor of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Here, we investigated the impact of telomere shortening, a physiological hallmark of aging, on brain function. Telomere-shortened mice exhibited cognitive decline and exacerbated lipofuscinosis, accompanied by the emergence of senescent microglia with a senescence-associated secretory phenotype and oligodendrocyte lineage cells with impaired maturation. Using iPSC-derived microglia with shortened telomeres, we identified DLK1 as a novel senescence-associated ligand secreted by senescent microglia. Elevated soluble DLK1 was detected in the cerebrospinal fluid of both telomere-shortened and physiologically aged mice, and this increase was abolished by microglial depletion, confirming its microglial origin. Functionally, AAV-mediated expression of sDLK1 in mouse brains induced hypomyelination and disrupted oligodendrocyte differentiation in vivo. In human iPSC-derived systems, sDLK1 impaired late-stage oligodendrocyte maturation and disrupted neuronal calcium signaling. Together, these findings establish replicative microglial senescence as a pathological feature of telomere shortening and identify sDLK1 as one key effector linking senescent microglia to oligodendrocyte dysfunction and neuronal dysregulation during brain aging.</description><dates><publication>2026/07/09</publication></dates><accession>GSE315100</accession><cross_references><GSM>GSM9421149</GSM><GSM>GSM9421148</GSM><GSM>GSM9421169</GSM><GSM>GSM9421147</GSM><GSM>GSM9421146</GSM><GSM>GSM9421168</GSM><GSM>GSM9421145</GSM><GSM>GSM9421167</GSM><GSM>GSM9421166</GSM><GSM>GSM9421144</GSM><GSM>GSM9421165</GSM><GSM>GSM9421164</GSM><GSM>GSM9421163</GSM><GSM>GSM9421162</GSM><GSM>GSM9421161</GSM><GSM>GSM9421160</GSM><GSM>GSM9421159</GSM><GSM>GSM9421158</GSM><GSM>GSM9421157</GSM><GSM>GSM9421156</GSM><GSM>GSM9421155</GSM><GSM>GSM9421154</GSM><GSM>GSM9421153</GSM><GSM>GSM9421152</GSM><GSM>GSM9421151</GSM><GSM>GSM9421150</GSM><GSM>GSM9421171</GSM><GSM>GSM9421170</GSM><GPL>24676</GPL><GSE>315100</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>